Hennion & Walsh Asset Management, Inc. Pliant Therapeutics, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.15 Billion
- Q1 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 104,430 shares of PLRX stock, worth $164,999. This represents 0.01% of its overall portfolio holdings.
Number of Shares
104,430
Previous 108,608
3.85%
Holding current value
$164,999
Previous $1.43 Million
89.3%
% of portfolio
0.01%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding PLRX
# of Institutions
154Shares Held
62.2MCall Options Held
279KPut Options Held
7.1K-
Tang Capital Management LLC San Diego, CA6MShares$9.48 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.4MShares$8.53 Million0.25% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$7.86 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$5.27 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.05MShares$4.82 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $76.9M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...